ProKidney Establishes At-the-Market Offering of Up to $200 Million

ProKidney entered into an agreement with Jefferies to sell up to $200 million of its Class A common stock. Jefferies may receive compensation of up to 3.0% of gross proceeds from shares sold, plus reimbursement for certain expenses.